JUM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spiezia, S.
Right arrow Articles by Colao, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spiezia, S.
Right arrow Articles by Colao, A.

Journal of Ultrasound in Medicine, Vol 20, Issue 3 223-231, Copyright © 2001 by American Institute of Ultrasound in Medicine


JOURNAL ARTICLE

Analysis of color Doppler signal intensity variation after levovist injection: a new approach to the diagnosis of thyroid nodules

S. Spiezia, R. Farina, G. Cerbone, A. P. Assanti, V. Iovino, M. Siciliani, G. Lombardi and A. Colao
Department of Surgery, Azienda Sanitaria Locale Napoli 1, Santa Maria del Popolo degli Incurabili Hospital, Naples, Italy.

The objective of this study was to evaluate the usefulness of a galactose-based ultrasonographic contrast agent, Levovist (Schering AG, Berlin, Germany), in differentiating benign from malignant thyroid nodules by analysis of the time-intensity curves correlating the variation of the intensity signal value during the contrast transit time. Fifty-four patients scheduled for surgical removal of a nodule or the thyroid gland or both after cytologic examination were enrolled in this study; all of the nodules underwent a baseline color and power Doppler evaluation and then to a color Doppler examination after an intravenous bolus injection of Levovist. The time-intensity curves were analyzed with respect to the histologic results. Carcinomas showed a significantly earlier arrival time of Levovist than nodular hyperplastic benign nodules and adenomas (8.1 +/- 1.41 versus 19.6 +/- 2.2 and 16.1 +/- 2.8 seconds; P < .0001), although no significant difference occurred between hyperplastic benign nodules and adenomas; carcinomas and adenomas showed an earlier time to peak than hyperplastic benign nodules (14.6 +/- 1.2 and 23.1 +/- 3.8 versus 33.0 +/- 3.0 seconds; P < .0001). No significant difference was found in baseline, peak, final intensity signal, and percent variation of intensity signal among hyperplastic benign nodules, adenomas, and carcinomas. Although cytologic examination still remains the standard of reference for the presurgical diagnosis of thyroid nodules, the preliminary data of this pilot study demonstrate that the analysis of time-intensity curves after Levovist injection might provide useful, complementary, and quantitative information to differentiate benign from malignant thyroid nodules.


This article has been cited by other articles:


Home page
J Ultrasound MedHome page
J. Li, B.-w. Dong, X.-l. Yu, and C.-f. Li
Gray Scale Contrast Enhancement and Quantification in Different Positions of Rabbit Liver
J. Ultrasound Med., January 1, 2006; 25(1): 7 - 14.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
J. Li, B.-w. Dong, X.-l. Yu, X.-h. Wang, and C.-f. Li
Time-Intensity-Based Quantification of Vascularity With Single-Level Dynamic Contrast-Enhanced Ultrasonography: A Pilot Animal Study
J. Ultrasound Med., July 1, 2005; 24(7): 975 - 983.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Institute of Ultrasound in Medicine.